Matches in SemOpenAlex for { <https://semopenalex.org/work/W2112833504> ?p ?o ?g. }
- W2112833504 endingPage "681" @default.
- W2112833504 startingPage "674" @default.
- W2112833504 abstract "To report the clinical characteristics of infectious endophthalmitis after Boston type I keratoprosthesis (K-Pro) implantation.Retrospective study.One hundred forty-one adult eyes receiving a K-Pro at a single institution from May 2004 through July 2008.A retrospective chart review was performed of all adult eyes receiving a K-Pro at the University of Rochester from May 2004 through July 2008. Those patients identified as having been treated for exogenous bacterial endophthalmitis were reviewed for demographic data, indication for K-Pro, bandage contact lens use, prophylactic antibiotic use, timing and clinical presentation of endophthalmitis, gram stain and culture results of intraocular fluid, timing and presentation of any subsequent episodes of endophthalmitis (recurrent endophthalmitis), and preoperative and postoperative visual acuity through August 2010.Incidence of endophthalmitis, time to occurrence, recurrence rates, visual outcomes, and risk factors associated with K-Pro endophthalmitis.Ten (7.1%) of 141 eyes of 130 adult patients were diagnosed and treated for bacterial endophthalmitis. Average time to endophthalmitis developing after K-Pro was 9.8 months (standard deviation [SD], 6.2 months; range, 2-25 months). Coagulase-negative staphylococci were identified in 7 eyes. In 7 of the 10 eyes, recurrent endophthalmitis developed that occurred at a mean of 4 months (SD, 3.9 months; range, 1-13 months) after resolution of the initial episode. At each episode of endophthalmitis, no eye was receiving vancomycin ophthalmic drops and most eyes were receiving only fluoroquinolone ophthalmic drops for prophylaxis.Infectious endophthalmitis after K-Pro implantation has a higher incidence, delayed onset, and high risk for recurrence compared with postoperative endophthalmitis associated with more common intraocular procedures such as cataract surgery. The concurrent use of topical vancomycin is recommended because it seems to be important in reducing the incidence and recurrence of endophthalmitis and because fluoroquinolone ophthalmic drops do not seem to be sufficient prophylaxis in these eyes." @default.
- W2112833504 created "2016-06-24" @default.
- W2112833504 creator A5005041289 @default.
- W2112833504 creator A5009231666 @default.
- W2112833504 creator A5021380664 @default.
- W2112833504 creator A5049898173 @default.
- W2112833504 creator A5053262622 @default.
- W2112833504 creator A5058291478 @default.
- W2112833504 creator A5066505961 @default.
- W2112833504 date "2012-04-01" @default.
- W2112833504 modified "2023-09-27" @default.
- W2112833504 title "Infectious Endophthalmitis in Adult Eyes Receiving Boston Type I Keratoprosthesis" @default.
- W2112833504 cites W140121161 @default.
- W2112833504 cites W182368755 @default.
- W2112833504 cites W1983737138 @default.
- W2112833504 cites W1996684979 @default.
- W2112833504 cites W2000897442 @default.
- W2112833504 cites W2023451731 @default.
- W2112833504 cites W2032070767 @default.
- W2112833504 cites W2054152044 @default.
- W2112833504 cites W2059114494 @default.
- W2112833504 cites W2067852897 @default.
- W2112833504 cites W2068672816 @default.
- W2112833504 cites W2070554206 @default.
- W2112833504 cites W2073094745 @default.
- W2112833504 cites W2074771990 @default.
- W2112833504 cites W2085935533 @default.
- W2112833504 cites W2121949549 @default.
- W2112833504 cites W2122434128 @default.
- W2112833504 cites W2124620383 @default.
- W2112833504 cites W2125243790 @default.
- W2112833504 cites W2137334018 @default.
- W2112833504 cites W2140056777 @default.
- W2112833504 cites W2147222910 @default.
- W2112833504 cites W2330446371 @default.
- W2112833504 cites W4238283560 @default.
- W2112833504 cites W4253875289 @default.
- W2112833504 cites W4301735520 @default.
- W2112833504 doi "https://doi.org/10.1016/j.ophtha.2011.10.009" @default.
- W2112833504 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22266108" @default.
- W2112833504 hasPublicationYear "2012" @default.
- W2112833504 type Work @default.
- W2112833504 sameAs 2112833504 @default.
- W2112833504 citedByCount "50" @default.
- W2112833504 countsByYear W21128335042012 @default.
- W2112833504 countsByYear W21128335042013 @default.
- W2112833504 countsByYear W21128335042014 @default.
- W2112833504 countsByYear W21128335042015 @default.
- W2112833504 countsByYear W21128335042016 @default.
- W2112833504 countsByYear W21128335042018 @default.
- W2112833504 countsByYear W21128335042020 @default.
- W2112833504 countsByYear W21128335042021 @default.
- W2112833504 countsByYear W21128335042022 @default.
- W2112833504 countsByYear W21128335042023 @default.
- W2112833504 crossrefType "journal-article" @default.
- W2112833504 hasAuthorship W2112833504A5005041289 @default.
- W2112833504 hasAuthorship W2112833504A5009231666 @default.
- W2112833504 hasAuthorship W2112833504A5021380664 @default.
- W2112833504 hasAuthorship W2112833504A5049898173 @default.
- W2112833504 hasAuthorship W2112833504A5053262622 @default.
- W2112833504 hasAuthorship W2112833504A5058291478 @default.
- W2112833504 hasAuthorship W2112833504A5066505961 @default.
- W2112833504 hasConcept C118487528 @default.
- W2112833504 hasConcept C120665830 @default.
- W2112833504 hasConcept C121332964 @default.
- W2112833504 hasConcept C141071460 @default.
- W2112833504 hasConcept C167135981 @default.
- W2112833504 hasConcept C2776053893 @default.
- W2112833504 hasConcept C2777235844 @default.
- W2112833504 hasConcept C2778257484 @default.
- W2112833504 hasConcept C2778980435 @default.
- W2112833504 hasConcept C2779489039 @default.
- W2112833504 hasConcept C523546767 @default.
- W2112833504 hasConcept C54355233 @default.
- W2112833504 hasConcept C61511704 @default.
- W2112833504 hasConcept C71924100 @default.
- W2112833504 hasConcept C86803240 @default.
- W2112833504 hasConceptScore W2112833504C118487528 @default.
- W2112833504 hasConceptScore W2112833504C120665830 @default.
- W2112833504 hasConceptScore W2112833504C121332964 @default.
- W2112833504 hasConceptScore W2112833504C141071460 @default.
- W2112833504 hasConceptScore W2112833504C167135981 @default.
- W2112833504 hasConceptScore W2112833504C2776053893 @default.
- W2112833504 hasConceptScore W2112833504C2777235844 @default.
- W2112833504 hasConceptScore W2112833504C2778257484 @default.
- W2112833504 hasConceptScore W2112833504C2778980435 @default.
- W2112833504 hasConceptScore W2112833504C2779489039 @default.
- W2112833504 hasConceptScore W2112833504C523546767 @default.
- W2112833504 hasConceptScore W2112833504C54355233 @default.
- W2112833504 hasConceptScore W2112833504C61511704 @default.
- W2112833504 hasConceptScore W2112833504C71924100 @default.
- W2112833504 hasConceptScore W2112833504C86803240 @default.
- W2112833504 hasIssue "4" @default.
- W2112833504 hasLocation W21128335041 @default.
- W2112833504 hasLocation W21128335042 @default.
- W2112833504 hasOpenAccess W2112833504 @default.
- W2112833504 hasPrimaryLocation W21128335041 @default.
- W2112833504 hasRelatedWork W2011194010 @default.